久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Ligand, WuXi Biologics Amend Agreement contractpharma
    July 03, 2018
    Ligand Pharmaceuticals?has received $47 million as a result of signing an amendment relating to its OmniAb platform agreement with?WuXi Biologics. This amendment provides WuXi Bio more efficiency in expanding its OmniAb antibody discovery services.
  • Ligand Earns Janssen Milestone contractpharma
    March 29, 2017
    CNA Development LLC has filed an IND for an antibody discovered using Ligand’s OmniAb technology triggering a $1 million milestone payment to Ligand.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service